Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative GI recovery after laparoscopic colorectal surgery
ChiCTR2500108216Phase 4Not yet recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain and Postoperative gastrointestinal dysfunction (POGD) (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Comparison of postoperative I-FEED scores. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative painPostoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on ChiCTR2500108216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108216.